Bernard Collins is a Principal Scientist/Sr Scientific Lead at Loxo@Lilly, specializing in x-ray crystallography and structural biology. With over 20 years of experience in both academic and industry settings, they have contributed to projects focused on structure-based drug design for various therapeutic areas, particularly oncology. Collins has previously worked at notable companies including The Janssen Pharmaceutical Companies of Johnson & Johnson and Plex Pharmaceuticals, where they optimized lead compounds and led crystallography efforts. They earned a Ph.D. in Biochemistry and Molecular Genetics from the University of Colorado Anschutz Medical Campus and a B.S. in Biochemistry from Colorado State University.
This person is not in any teams
This person is not in any offices